Empowering States to Address Drug Costs Act

Bill: 116-s-2252
Sponsor: full_name: Sen. Van Hollen, Chris [D-MD]
Introduced: 2019-07-24
Policy area: Health
Subjects: Business records

Government information and archives

Health care costs and insurance

Inflation and prices

Medicaid

Prescription drugs

State and local government operations
Latest action: action_date: 2019-07-24
text: Read twice and referred to the Committee on Finance.

Summaries:
action_date: 2019-07-24
action_desc: Introduced in Senate
text: <p><b>Empowering States to Address Drug Costs Act</b></p> <p>This bill expands the purposes for which states may use certain drug pricing information that is disclosed to them by manufacturers through the Medicaid Drug Rebate Program. Specifically, the bill allows states to use such information in furtherance of prescription drug affordability boards or state multi-payer purchasing pools.</p>

tv_txt: II 116th CONGRESS 1st Session S. 2252 IN THE SENATE OF THE UNITED STATES July 24, 2019 Mr. Van Hollen (for himself and Mr. Cardin ) introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To amend title XIX of the Social Security Act to expand the permitted uses of drug price information disclosed to States under the Medicaid drug rebate program.

1. Short title This Act may be cited as the Empowering States to Address Drug Costs Act . 2. Expansion of permitted uses of drug price information disclosed to States under Medicaid drug rebate program Clause (iv) of section 1927(b)(3)(D) of the Social Security Act ( 42 U.S.C. 1396r–8(b)(3)(D) ) is amended to read as follows: (iv) to States— (I) to carry out this title, or (II) to review the information provided (including average manufacturer price, best price, and rebate calculation data) for the purposes of establishing and operating State all-payer prescription drug rate setting entities (drug affordability boards) or State multi-payer purchasing pools, .